Business Context and Reporting Period
Company: The Coca-Cola Company
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2004
Reporting Scope: Unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2004, compared to the same periods in 2003.
Key Financial Metrics
| Metric (in millions) | 3 Months Ended Sep 30, 2004 | 9 Months Ended Sep 30, 2004 | 9 Months Ended Sep 30, 2003 |
|---|---|---|---|
| Net Operating Revenues | $5,662 | $16,705 | $15,868 |
| Gross Profit | $3,610 | $10,870 | $9,956 |
| Operating Income | $1,097 | $4,351 | $4,129 |
| Net Income | $935 | $3,646 | $3,420 |
| Diluted EPS | $0.39 | $1.50 | $1.39 |
| Cash & Equivalents (Balance Sheet) | $5,365 (Sep 30, 2004) | N/A | |
| Net Cash from Operating Activities | N/A | $4,590 | $4,121 |
| Total Debt (Current + Long-Term) | $6,518 (Sep 30, 2004) | N/A |
Note: Total Debt calculated as Loans/Notes Payable ($3,946M) + Current Maturities ($1,384M) + Long-Term Debt ($1,188M).
Material Changes vs. Prior Period
- Revenue: Nine-month revenue increased 5% ($837M) driven by a 3% increase in gallon sales and favorable currency fluctuations (stronger Euro and Yen). Third-quarter revenue was flat (-0.2%) due to a 1% decline in gallon sales offset by currency benefits.
- Profitability: Operating income for the third quarter decreased 24% ($354M) primarily due to $392M in impairment charges related to German franchise rights. Nine-month operating income increased 5% despite these charges.
- Impairment Charges: The company recorded $392M in impairment charges in Q3 2004 (primarily Germany) and $88M in Q2 2004. This contrasts with $55M in "Other operating charges" in Q3 2003.
- Equity Income: Equity income increased significantly in Q3 2004 ($180M vs $86M in 2003) due to the absence of a $95M non-cash charge recorded in Q3 2003 related to Coca-Cola FEMSA.
- Cash Flow: Operating cash flow increased 11% year-over-year for the nine-month period to $4.59B, supported by higher net income and working capital management.
Guidance, Outlook, and Risks
- Outlook: Management expects challenging conditions to persist in North America, Germany, and Northern Europe for the remainder of 2004. Currency benefits are expected to be substantially less in Q4 2004 compared to Q3.
- Share Repurchases: The company expects 2004 share repurchase levels to be at least $2 billion. As of September 30, 2004, approximately $1.43B had been spent on repurchases.
- Dividends: Quarterly dividend increased to $0.25 per share in 2004 from $0.22 in 2003.
- Legal & Regulatory:
- European Commission: The company submitted a formal "Undertaking" to the European Commission regarding commercial practices in 27 countries. This is expected to end the investigation but imposes restrictions on exclusivity and rebates.
- SEC/Criminal Investigation: Ongoing investigations regarding allegations by a former employee; no prosecutions filed to date.
- Aqua-Chem Litigation: Dispute regarding asbestos liability from a former subsidiary; litigation stayed pending insurance resolution.
- Accounting Changes: Adoption of FASB Interpretation No. 46 resulted in the consolidation of certain variable interest entities (bottlers) effective March 31, 2004, adding approximately $383M in assets and liabilities.
Investor Verification Checklist
- Germany Impairment: Verify the sustainability of the $392M impairment charge related to CCEAG franchise rights and the impact of German deposit laws on future volume.
- Currency Sensitivity: Assess the risk of reduced currency benefits in Q4 2004 and the potential impact of a strengthening U.S. dollar on future earnings.
- European Undertaking: Monitor the implementation of the European Commission Undertaking and its effect on pricing power and distribution agreements in Europe.
- Volume Trends: Confirm the causes of the 3% volume decline in North America and 3% decline in Europe (Q3) and whether these are temporary or structural.
- Debt Structure: Review the increase in short-term debt (commercial paper) used to fund dividends and share repurchases.